Aehr Test Systems (AEHR) saw its stock price plummet 9.95% during intraday trading on Friday, marking a sharp reversal from recent gains.
The decline is attributed to significant profit-taking pressure following multiple consecutive sessions of strong performance, which had been driven by an oversold recovery and a $41 million AI chip testing order. Additionally, investor sentiment continues to be weighed down by lingering concerns over potential share dilution stemming from the company's earlier $60 million common stock public offering.
The weakness was amplified by broad selling pressure across the semiconductor equipment sector, with major peers like ASML Holding, Lam Research, and Applied Materials also trading lower during the session.
Comments